YD Bio Launches AI Cancer Risk Assessment Tool

YD Bio has launched a new AI-powered cancer risk assessment tool that evaluates risk for 10 different types of cancer. The service is priced at $10 during an introductory promotional period and is integrated with the company's existing oncology services.